Toll-like receptors in normal and malignant human bladders

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1915-1921

  Ayari, Cherifa ^a   Bergeron, Alain ^a   Larue, Hlne ^a   Mnard, Claire ^a   Fradet, Yves ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

immunotherapy; toll like receptors; urinary bladder; urinary bladder neoplasms; urothelium

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UROTHELIUM;

BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MYCOBACTERIUM BOVIS; NF-KAPPA B; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TUMOR CELLS, CULTURED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79953778800     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.097     Document Type: Article

References (30)

1. G. Apodaca The uroepithelium: not just a passive barrier Traffic 5 2004 117
2. L.A. Birder Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli Vascul Pharmacol 45 2006 221
3. R.F. Bevers, K.H. Kurth, and D.H. Schamhart Role of urothelial cells in BCG immunotherapy for superficial bladder cancer Br J Cancer 91 2004 607
4. R. Medzhitov Recognition of microorganisms and activation of the immune response Nature 449 2007 819
5. S. Rakoff-Nahoum, and R. Medzhitov Toll-like receptors and cancer Nat Rev Cancer 9 2009 57
6. A. Ozinsky, D.M. Underhill, and J.D. Fontenot The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors Proc Natl Acad Sci USA 97 2000 13766
7. L. Yu, and S. Chen Toll-like receptors expressed in tumor cells: targets for therapy Cancer Immunol Immunother 57 2008 1271
8. X. Li, S. Jiang, and R.I. Tapping Toll-like receptor signaling in cell proliferation and survival Cytokine 49 2010 1
9. Y. Qian, J. Deng, and H. Xie Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling J Cancer Res Clin Oncol 135 2009 379
10. J. Southgate, K.A. Hutton, and D.F. Thomas Normal human urothelial cells in vitro: proliferation and induction of stratification Lab Invest 71 1994 583
11. V. Picard, A. Bergeron, and H. LaRue MAGE-A9 mRNA and protein expression in bladder cancer Int J Cancer 120 2007 2170
12. K.P. van Gisbergen, M. Sanchez-Hernandez, and T.B. Geijtenbeek Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN J Exp Med 201 2005 1281
13. J. Sun, and X. Lin Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation Proc Natl Acad Sci USA 105 2008 17085
14. H. LaRue, C. Parent-Vaugeois, and A. Bergeron Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer Int J Cancer 71 1997 986
15. D. Zhang, G. Zhang, and M.S. Hayden A toll-like receptor that prevents infection by uropathogenic bacteria Science 303 2004 1522
16. J. Song, and S.N. Abraham TLR-mediated immune responses in the urinary tract Curr Opin Microbiol 11 2008 66
17. Y. Qian, J. Deng, and L. Geng TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells Cancer Invest 26 2008 816
18. J. Song, M.J. Duncan, and G. Li A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells PLoS Pathog 3 2007 e60
19. J. Song, and S.N. Abraham Innate and adaptive immune responses in the urinary tract Eur J Clin Invest 38 suppl. 2008 21
20. S. Allhorn, C. Boing, and A.A. Koch TLR3 and TLR4 expression in healthy and diseased human endometrium Reprod Biol Endocrinol 6 2008 40
21. I. Niedzielska, Z. Niedzielski, and M. Tkacz Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer J Physiol Pharmacol 60 suppl. 2009 65
22. R. Chen, A.B. Alvero, and D.A. Silasi Cancers take their Tollthe function and regulation of Toll-like receptors in cancer cells Oncogene 27 2008 225
23. M. Zietarska, C.M. Maugard, and A. Filali-Mouhim Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC) Mol Carcinog 46 2007 872
24. R.J. Sylvester, A.P. Van der Meijden, and J.A. Witjes Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials J Urol 174 2005 86
25. R.F. Han, and J.G. Pan Can intravesical bacillus Calmette-Gurin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials Urology 67 2006 1216
26. E.J. Hennessy, A.E. Parker, and L.A. O'Neill Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9 2010 293
27. A. Hegele, A. Dalpke, and K. Heeg Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model Tumour Biol 26 2005 274
28. P.J. Olbert, A.J. Schrader, and C. Simon In vitro and in vivo effects of CpG-oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall Anticancer Res 29 2009 2067
29. E.B. Smith, M. Schwartz, and H. Kawamoto Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder J Urol 177 2007 2347
30. L. Sagnak, H. Ersoy, and U. Ozok Predictive value of urinary interleukin-8 cutoff point for recurrences after transurethral resection plus induction bacillus Calmette-Gurin treatment in nonmuscle invasive bladder tumors Clin Genitourin Cancer 7 2009 E16